Related Experiment Video
Updated: Jan 22, 2026

Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
Quantification of Atherosclerosis in Mice
Monica Centa1, Daniel F J Ketelhuth2, Stephen Malin1
1Cardiovascular Medicine Unit, Center for Molecular Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital.
Insights
This study presents a standardized protocol for evaluating atherosclerosis in mouse models. This method enhances reproducibility and reduces variability in experimental atherosclerosis research.
Area of Science:
- Cardiovascular research
- Immunology
- Pathology
Background:
- Cardiovascular disease (CVD) is a leading global cause of mortality.
- Atherosclerosis, a primary driver of CVD, involves chronic inflammation and lipid accumulation.
- Previous research in mouse models has identified key roles for cholesterol and inflammation.
Purpose of the Study:
- To provide a standardized protocol for evaluating atherosclerosis in mouse models.
- To enable comprehensive lesion analysis at multiple arterial sites within a single animal.
- To improve reproducibility and reduce variability in experimental atherosclerosis studies.
Main Methods:
- Detailed technical description for evaluating atherosclerotic lesions.
- Focuses on lesion quantification in the aortic root, aortic arch, and brachiocephalic artery.
- Designed for efficient use of limited biological material, such as in genetically modified mouse studies.
Main Results:
- The protocol allows for simultaneous assessment of atherosclerosis at critical vascular sites.
- Standardization of lesion analysis minimizes experimental variability.
- Increases the reproducibility of findings in atherosclerosis research.
Conclusions:
- This protocol offers a valuable tool for researchers studying atherosclerosis pathogenesis.
- It is particularly useful for characterizing atherosclerosis in genetically modified mouse models.
- Standardized analysis is crucial for advancing our understanding and treatment of atherosclerosis.
Abstract:
Cardiovascular disease is the main cause of death in the world. The underlying cause in most cases is atherosclerosis, which is in part a chronic inflammatory disease. Experimental atherosclerosis studies have elucidated the role of cholesterol and inflammation in the disease process. This has led to successful clinical trials with pharmaceutical agents that reduce clinical manifestations of atherosclerosis. Careful and well-controlled experiments in mouse models of the disease could further elucidate the pathogenesis of the disease, which is not fully understood. Standardized lesion analysis is important to reduce experimental variability and increase reproducibility. Determining lesion size in aortic root, aortic arch, and brachiocephalic artery are common endpoints in experimental atherosclerosis. This protocol provides a technical description for evaluation of atherosclerosis at all these sites in a single mouse. The protocol is particularly useful when material is limited, as is frequently the case when genetically modified animals are being characterized.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis IV: Nursing Management
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
In-vitro Mutagenesis

